Global healthcare merger and acquisition (M&A) activity rebounded strongly in 2025, with deal value rising 38% to US$546.7bn, marking one of the strongest years since the post-pandemic peak. However, within this broader upswing, mid-market healthcare M&A showed more modest growth. The latest review of global healthcare M&A by Baker Tilly International, produced in conjunction with Mergermarket, shows mid-market deal value increased 2% to US$105bn, marking the third consecutive year of growth since 2023, but trailing the wider mid-market (all sectors), where deal value rose 7%. The divergence is even more evident in volumes.
Read the full article: Healthcare M&A Rebalances //
Source: https://www.bakertilly.global/insights/healthcare-m-a-rebalances